Latest 10-K annual reports

Daktronics achieved significant growth in fiscal 2026, reporting $838.7 million in net sales and a return to profitability with $45.4 million in net income.

Methode Electronics reports a net loss of $35.7 million for fiscal 2026 as it navigates program roll-offs and restructuring.

The Crypto Company filed an amended 10-K for fiscal year 2024 to correct a material error regarding unrecorded derivative liabilities on convertible debt.

Sui Group Holdings Limited filed an amendment to its 2025 Annual Report to correct exhibit hyperlinks and provide updated certifications.

John Wiley & Sons reports stable annual revenue of $1.68 billion and a 25% increase in operating income for fiscal year 2026.

Crown Crafts, Inc. reports fiscal 2026 net income of $1.8 million, rebounding from a prior year loss, despite a 5.7% decline in net sales.

Jerash Holdings (US), Inc. announced a 14% increase in revenue for fiscal year 2026, reaching $166.3 million, driven by new customer acquisitions and expanded sales with existing clients.

Central Plains Bancshares, Inc. announced its fiscal year 2026 results, showing a 9.5% increase in net income to $4.0 million, driven by loan portfolio growth and improved net interest margin.

Medtronic plc reported robust financial results for fiscal year 2026, driven by significant growth across its key business segments.

Grace Therapeutics reported a net loss for the fiscal year ended March 31, 2026, and received a Complete Response Letter from the FDA for its GTx-104 drug candidate.

InnSuites Hospitality Trust files an amendment to its 2026 10-K to correct the audit opinion letter date and reclassify mortgage notes payable.

Earth Science Tech, Inc. (ETST) announced its fiscal year 2026 results, showing an 8% increase in revenue to $35.7 million, driven by strong demand in its compounding pharmacy and telemedicine segments.

DT Cloud Star Acquisition Corporation filed an amendment to its 2025 Annual Report, confirming a pending business combination with PrimeGen US, Inc.

Smith & Wesson Brands, Inc. announced its fiscal year 2026 results, showing a notable increase in net sales and net income compared to the previous year.

Satellogic Inc. has filed an amendment to its 2025 Annual Report on Form 10-K solely to re-file specific CEO and CFO certifications.

VitaSpring Biomedical Co., Ltd. filed its annual report, highlighting substantial doubt about its ability to continue as a going concern due to a lack of revenue and significant liabilities.

Pulmatrix, Inc. filed an amended annual report to correct a typographical error and provided updated financial statements showing reduced operating expenses and net loss, while awaiting critical regulatory approval for its merger with Cullgen Inc.

La-Z-Boy Incorporated announced its fiscal year 2026 results, showing a slight increase in sales driven by retail acquisitions and strategic pricing, while navigating challenges in international markets and managing operational transformations.

Sonoma Pharmaceuticals, Inc. announced its fiscal year 2026 results, highlighting a 37% increase in total revenue to $19.5 million, driven by strong performance in the United States and international markets.

Autonomix Medical, Inc. filed an amendment to its 2026 Annual Report to include required Part III disclosures regarding governance and executive compensation.

Credo Technology Group reported significant fiscal 2026 growth with $1.3 billion in revenue, driven by strong demand for AI-focused connectivity solutions.

Vistagen Therapeutics reported mixed results for its fasedienol clinical trials, with two Phase 3 trials failing to meet primary endpoints, while also announcing a workforce reduction and continued focus on cash management.

Powerfleet, Inc. announced its fiscal year 2026 results, showcasing a significant increase in total revenues driven by its services segment and strategic acquisitions.

Quantumsphere Acquisition Corporation filed its Form 10-K for the fiscal year ended March 31, 2026, detailing its ongoing search for a business combination and financial status.

Canopy Growth Corporation has filed its Form 10-K for the fiscal year ended March 31, 2026, detailing financial restatements due to accounting errors related to share-settled warrants and reporting a reduced net loss compared to the prior year.

INVO Fertility, Inc. filed an amendment to its 2025 Annual Report to provide required Part III proxy information and updated certifications.

Brown-Forman Corporation reported a 1% decrease in net sales to $3.9 billion for fiscal 2026, alongside a 10% drop in operating income, reflecting challenging macroeconomic conditions and strategic portfolio adjustments.

Riverview Bancorp, Inc. reported a net loss of $4.3 million for fiscal 2026, primarily driven by a $11.4 million pre-tax loss from a strategic investment portfolio repositioning.

BIO-key International reports a net loss of $7.16 million for 2025 amid ongoing liquidity challenges and Nasdaq delisting.

IEH Corporation reports a net loss of $1.3 million for fiscal 2026 despite revenue growth, citing increased operating costs and material weaknesses in internal controls.